Alerts will be sent to your verified email
Verify Email
CHECKPOINT
|
Rubra Medicaments
|
Dipna Pharma.
|
QVC Exports
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
2.23 % | 16.1 % | 9.51 % |
|
5yr average Equity Multiplier
|
1.43 | 14.87 | 2.34 |
|
5yr Average Asset Turnover Ratio
|
1.33 | 1.35 | 2.8 |
|
5yr Avg Net Profit Margin
|
0.06 % | 0.81 % | 1.37 % |
|
Price to Book
|
11.69 | 0.41 | 0.0 |
|
P/E
|
11.03 | 24.29 | 2.99 |
|
5yr Avg Cash Conversion Cycle
|
362.19 Days | -33.62 Days | 53.44 Days |
|
Inventory Days
|
0.0 | 62.45 Days | 6.68 Days |
|
Days Receivable
|
362.19 Days | 112.8 Days | 50.62 Days |
|
Days Payable
|
18.78 Days | 139.84 Days | 7.19 Days |
|
5yr Average Interest Coverage Ratio
|
-272.71 | 2.01 | 2.0 |
|
5yr Avg ROCE
|
-0.79 % | 12.33 % | 16.98 % |
|
5yr Avg Operating Profit Margin
|
1.78 % | 2.41 % | -4.9 % |
|
5 yr average Debt to Equity
|
0.06 | 5.84 | 1.14 |
|
5yr CAGR Net Profit
|
24.57 % | 117.34 % | 57.17 % |
|
5yr Average Return on Assets
|
-1.69 % | 1.21 % | 3.82 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 9.98 % | 73.22 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -56.58 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Rubra Medicaments
|
Dipna Pharma.
|
QVC Exports
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
-
|
Product Wise Break-Up
|